(NYSE: PRGO) Perrigo Co's forecast annual revenue growth rate of 2.34% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.37%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.72%.
Perrigo Co's revenue in 2025 is $4,335,200,000.On average, 3 Wall Street analysts forecast PRGO's revenue for 2025 to be $611,057,754,936, with the lowest PRGO revenue forecast at $607,384,361,319, and the highest PRGO revenue forecast at $613,877,414,482. On average, 3 Wall Street analysts forecast PRGO's revenue for 2026 to be $624,288,020,956, with the lowest PRGO revenue forecast at $619,885,172,754, and the highest PRGO revenue forecast at $632,856,156,575.
In 2027, PRGO is forecast to generate $639,069,580,897 in revenue, with the lowest revenue forecast at $630,058,493,398 and the highest revenue forecast at $650,460,125,608.